financetom
Business
financetom
/
Business
/
Nasdaq Q3 Non-GAAP Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nasdaq Q3 Non-GAAP Earnings, Revenue Increase
Oct 21, 2025 4:50 AM

07:28 AM EDT, 10/21/2025 (MT Newswires) -- Nasdaq (NDAQ) reported Q3 non-GAAP earnings Tuesday of $0.88 per diluted share, up from $0.74 a year earlier.

Analysts polled by FactSet expected $0.85.

Revenue for the quarter ended Sept. 30 was $1.32 billion, up from $1.15 billion a year earlier.

Analysts surveyed by FactSet expected $1.30 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Genasys Insider Bought Shares Worth $264,000, According to a Recent SEC Filing
Genasys Insider Bought Shares Worth $264,000, According to a Recent SEC Filing
Dec 13, 2024
03:42 PM EST, 12/13/2024 (MT Newswires) -- Richard Hoe Osgood III, Director, on December 12, 2024, executed a purchase for 100,000 shares in Genasys ( GNSS ) for $264,000. Following the Form 4 filing with the SEC, Osgood has control over a total of 507,883 shares of the company, with 507,883 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/924383/000143774924037461/xslF345X05/rdgdoc.xml Price: 2.70, Change:...
J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports
J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports
Dec 13, 2024
Dec 13 (Reuters) - Johnson & Johnson ( JNJ ) has sued divisions of Cigna ( CI ), accusing the health insurer of working with a drug-benefit middleman to drain J&J's financial-assistance funds earmarked for patients taking some of its pricier drugs, The Wall Street Journal reported on Friday. ...
Terex Insider Bought Shares Worth $1,014,600, According to a Recent SEC Filing
Terex Insider Bought Shares Worth $1,014,600, According to a Recent SEC Filing
Dec 13, 2024
03:42 PM EST, 12/13/2024 (MT Newswires) -- David A Sachs, Director, on December 11, 2024, executed a purchase for 20,000 shares in Terex ( TEX ) for $1,014,600. Following the Form 4 filing with the SEC, Sachs has control over a total of 125,800 shares of the company, with 125,800 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/97216/000009721624000166/xslF345X05/wk-form4_1734122310.xml Price: 49.74, Change: -0.90, Percent...
Palvella Therapeutics Completes Merger with Pieris; Raises $78.9 Million in Private Placement
Palvella Therapeutics Completes Merger with Pieris; Raises $78.9 Million in Private Placement
Dec 13, 2024
03:35 PM EST, 12/13/2024 (MT Newswires) -- Palvella Therapeutics (PVLA) said Friday it has completed its merger with Pieris Pharmaceutical. The merged entity will be named Palvella Therapeutics, with its shares set to start trading on the Nasdaq Capital Market under the ticker PVLA on Monday. The clinical-stage biopharmaceutical company said it raised $78.9 million in a private placement co-led...
Copyright 2023-2026 - www.financetom.com All Rights Reserved